Jazz Pharmaceuticals JAZZ
NASDAQ JAZZ
$235.67 +2.66 (+1.14%)
At close: Oct 2, 2026 · 4:00 PM EDT

Jazz Pharmaceuticals (JAZZ) Cash & Equivalents (2010 - 2026)

Updated

Jazz Pharmaceuticals' Cash & Equivalents was $1.62 billion in Q2 2026, up 36.1% from $1.19 billion a year earlier but down 12.2% from the prior quarter.

Analysis

Jazz Pharmaceuticals (JAZZ) Cash & Equivalents (2010 - 2026) Analysis & Trends

At the end of FY2025, Cash & Equivalents at Jazz Pharmaceuticals came in at $1.39 billion, down 42.3% from FY2024.

  • Cash & Equivalents shows a five-year compound annual growth rate of 5.6% (FY2020 to FY2025).
  • In earlier years, Cash & Equivalents was $2.41 billion in FY2024 (+60.2%), $1.51 billion in FY2023 (+70.9%), $881.48 million in FY2022 (+49.0%) and $591.45 million in FY2021 (-44.1%).
  • Quarterly Cash & Equivalents has moved between $490.84 million (Q1 2022) and $2.41 billion (Q4 2024) over five years.
  • Compared with a year earlier, Cash & Equivalents was higher in four of the last eight quarters, with growth averaging 12.0%.
  • The best year-over-year quarter for Cash & Equivalents over five years was Q1 2023 (growth of 137.9%); the worst was Q1 2022 (a decline of 76.6%).
  • Per Business Quant data, JAZZ's Cash & Equivalents in the three quarters before Q2 2026 was $1.84 billion (Q1 2026), $1.39 billion (Q4 2025) and $1.33 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 20.42 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 6.57 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 4.89 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 3.18 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 976.00 Mn
10 Jazz Pharmaceuticals 15.13 Bn 8.94 Bn 1.09 Bn 1.62 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.62 Bn
Mar 31, 2026 1.84 Bn
Dec 31, 2025 1.39 Bn
Sep 30, 2025 1.33 Bn
Jun 30, 2025 1.19 Bn
Mar 31, 2025 1.86 Bn
Dec 31, 2024 2.41 Bn
Sep 30, 2024 2.22 Bn
Jun 30, 2024 1.36 Bn
Mar 31, 2024 1.44 Bn
Dec 31, 2023 1.51 Bn
Sep 30, 2023 1.34 Bn
Jun 30, 2023 1.28 Bn
Mar 31, 2023 1.17 Bn
Dec 31, 2022 881.48 Mn
Sep 30, 2022 839.36 Mn
Jun 30, 2022 711.27 Mn
Mar 31, 2022 490.84 Mn
Dec 31, 2021 591.45 Mn
Sep 30, 2021 671.78 Mn
API Access

Jazz Pharmaceuticals Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=JAZZ&period=max&api_key=YOUR_API_KEY